Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Anti-IgE Immunotherapy in Allergic Patients

This study has been completed.
Sponsor:
Information provided by:
Resistentia Pharmaceuticals AB
ClinicalTrials.gov Identifier:
NCT00439621
First received: February 22, 2007
Last updated: August 13, 2008
Last verified: August 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)